{
    "1634131647502200832": {
        "author_id": "5383942",
        "created_at": "2023-03-10T09:58:40.000Z",
        "edit_history_tweet_ids": [
            "1634131647502200832"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 117,
                    "normalized_text": "IFRS",
                    "probability": 0.4115,
                    "start": 114,
                    "type": "Other"
                },
                {
                    "end": 169,
                    "normalized_text": "GSKAnnualReport",
                    "probability": 0.575,
                    "start": 155,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 170,
                    "start": 154,
                    "tag": "GSKAnnualReport"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.com/en-gb/investor\u2026",
                    "end": 194,
                    "expanded_url": "https://www.gsk.com/en-gb/investors/cautionary-statement/",
                    "start": 171,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/investors/cautionary-statement/",
                    "url": "https://t.co/aMwwVKYi2V"
                }
            ]
        },
        "id": "1634131647502200832",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 2356,
            "like_count": 5,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 1
        },
        "text": "Please read this information regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures in our 2022 Annual Report #GSKAnnualReport https://t.co/aMwwVKYi2V"
    }
}